Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,361 public trials 406 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Active, Not Recruiting

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

NCT04666272

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Changsha, Hunan, China
View Trial Details
Active, Not Recruiting

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

NCT05488483

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Memorial Sloan Kettering Bergen (Consent only ) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Commack, New York, United States
  • Memorial Sloan - Kettering Cancer Center New York, United States
  • Helmholtz Institute (Data Analysis Only) Munich, Germany
View Trial Details
Active, Not Recruiting

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

NCT05987332

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

NCT03767348

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of Birmingham Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Carti Cancer Center Little Rock, Arkansas, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Intratumoral PH-762 for Cutaneous Carcinoma

NCT06014086

Conditions
Malignant Melanoma of Skin, Melanoma, Merkel Cell Carcinoma of Skin, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Paradigm Clinical Research San Diego, California, United States
  • Integrity Research Delray Beach, Florida, United States
  • Skin Cancer and Dermatology Institute Reno, Nevada, United States
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

NCT06190951

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UC San Diego La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 104 locations
View Trial Details

Related conditions